hello Bravo, interesting the question you asked ..

hello Bravo, interesting the question you asked ... my insignificant opinion is that, to receive an important "prize" from Barda, it is necessary to have political support or a big Pharma behind. For this reason I think that it isn't possible to obtain any significant contribution for Generex, and I also believe that the company has known this for months and that it is a reason why they have sought out lenders / partners abroad.

By the way, if I remember correctly, Moderna got more than 400 million from Barda ...
I have no precise idea of ​​how much it may cost to complete the research and testing process of a vaccine: certainly several hundred million ... And also for this reason I doubt that BK has the strength to finance the entire development. It may be / I hope that the Chinese have sufficient resources. .

Perhaps by making peptide test data public, and if these are as excellent as they appear, new lenders may be enticed to invest in Gnbt; moreover this could increase Ngio's valuation and be the springboard for Ngio's launch / listing

... .... hoping that the last month of the year will bring us the news we have been waiting for a long time .. Have a nice Sunday